TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TMDX TransMedics Group, Inc.

Pre-Mkt 02-24 09:12:09 EST

134.65

+0.40

+0.30%

盘前134.86

+0.21+0.16%

09:03 EST

High135.26	Low130.43	Vol621.10K
Open132.39	D1 Closing134.25	Amplitude3.60%
Mkt Cap4.60B	Tradable Cap4.44B	Total Shares34.17M
T/O82.77M	T/O Rate1.88%	Tradable Shares32.95M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TMDX","market":"US","secType":"STK","nameCN":"TransMedics Group, Inc.","latestPrice":134.65,"timestamp":1771880400000,"preClose":134.25,"halted":0,"volume":621097,"hourTrading":{"tag":"盘前","latestPrice":134.86,"preClose":134.65,"latestTime":"09:03 EST","volume":837,"amount":113581.80395999999,"timestamp":1771941781770,"change":0.21,"changeRate":0.00156,"amplitude":0.008838},"delay":0,"changeRate":0.0029795158286778822,"floatShares":32954993,"shares":34174325,"eps":2.48,"marketStatus":"Pre-Mkt","change":0.4,"latestTime":"02-24 09:12:09 EST","open":132.39,"high":135.26,"low":130.431,"amount":82772721.44322999,"amplitude":0.03597,"askPrice":135.89,"askSize":9,"bidPrice":134.8,"bidSize":100,"shortable":3,"etf":0,"ttmEps":2.48,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771943400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1556769600000,"exchange":"NASDAQ","adjPreClose":134.65,"preHourTrading":{"tag":"盘前","latestPrice":134.86,"preClose":134.65,"latestTime":"09:03 EST","volume":837,"amount":113581.80395999999,"timestamp":1771941781770,"change":0.21,"changeRate":0.00156,"amplitude":0.008838},"postHourTrading":{"tag":"盘后","latestPrice":134.2,"preClose":134.65,"latestTime":"19:57 EST","volume":9659,"amount":1300555.231,"timestamp":1771894621856,"change":-0.45,"changeRate":-0.003342,"amplitude":0.007427},"volumeRatio":0.9976250275785222,"impliedVol":0.8448,"impliedVolPercentile":0.676},"requestUrl":"/m/hq/s/TMDX/tweets","defaultTab":"tweets","newsList":[{"id":"2613297801","title":"TransMedics Reports NASDAQ Inducement Grants to 14 New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2613297801","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613297801?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:05","pubTimestamp":1771621528,"startTime":"0","endTime":"0","summary":"TransMedics Group Inc. granted inducement equity awards to 14 new employees, consisting of non-qualified stock options covering 40,089 shares and 26,549 restricted stock units. The options carry an exercise price of $135.50, vest 25% after one year with the remainder vesting monthly over the next three years, and have a 10-year term. The restricted stock units vest 25% on each of the first four anniversaries of the employee’s start date.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDLX3f76:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU2324357040.USD","BK4588","BK4585","LU2065731478.USD","TMDX"],"gpt_icon":0},{"id":"2612460157","title":"TransMedics Group Inc. Releases Investor Presentation Document","url":"https://stock-news.laohu8.com/highlight/detail?id=2612460157","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612460157?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:07","pubTimestamp":1771362426,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief on February 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL5RTgFL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","TMDX","BK4082","BK4585","LU2065731478.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"2612677460","title":"TransMedics Group to Present at Major Healthcare Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2612677460","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612677460?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:06","pubTimestamp":1771362402,"startTime":"0","endTime":"0","summary":"TransMedics Group to Present at Major Healthcare Investor Conferences               TransMedics Group Inc. will participate in two upcoming investor conferences. The company is scheduled for a firesid","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL3PJfWf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU2065731478.USD","BK4585","BK4588","BK4082","TMDX"],"gpt_icon":0},{"id":"1164102367","title":"Earning Preview: TransMedics Group, Inc. this quarter’s revenue is expected to increase by 41.20%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1164102367","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164102367?lang=en_us&edition=fundamental","pubTime":"2026-02-17 14:51","pubTimestamp":1771311106,"startTime":"0","endTime":"0","summary":"Abstract TransMedics Group, Inc. is scheduled to release its quarterly results on February 24, 2026 Post Market, and consensus points to strong year-over-year expansion in revenue and earnings amid...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: TransMedics Group, Inc. this quarter’s revenue is expected to increase by 41.20%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMDX"],"gpt_icon":0},{"id":"2611612165","title":"Stifel Nicolaus Sticks to Its Hold Rating for TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2611612165","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611612165?lang=en_us&edition=fundamental","pubTime":"2026-02-13 22:55","pubTimestamp":1770994549,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Thomas Stephan maintained a Hold rating on TransMedics Group today and set a price target of $115.00. Stephan covers the He...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-sticks-to-its-hold-rating-for-transmedics-group-tmdx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-sticks-to-its-hold-rating-for-transmedics-group-tmdx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","TMDX"],"gpt_icon":0},{"id":"2611970103","title":"TransMedics Group Inc. Files Initial Beneficial Ownership Statement for Chief Commercial Officer Giovanni Cecere","url":"https://stock-news.laohu8.com/highlight/detail?id=2611970103","media":"Reuters","labels":["executive","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611970103?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:15","pubTimestamp":1770930940,"startTime":"0","endTime":"0","summary":"TransMedics Group Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Giovanni Cecere, Chief Commercial Officer, as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDLb0B0Pm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"TransMedics Group Inc. Files Initial Beneficial Ownership Statement for Chief Commercial Officer Giovanni Cecere","news_tag":"executive,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","TMDX","BK4585","BK4082","BK4588","LU2324357040.USD"],"gpt_icon":0},{"id":"2610676988","title":"TransMedics Group Inc. to Release Fourth Quarter and Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2610676988","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610676988?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:06","pubTimestamp":1770757606,"startTime":"0","endTime":"0","summary":"TransMedics Group Inc. will release its fourth quarter and full year 2025 financial results after market close on Tuesday, February 24, 2026. The company's management team will host a conference call to discuss the results at 4:30 p.m. ET / 1:30 p.m. PT. A live and archived webcast of the event will be available on the Investors section of the TransMedics website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via PR Newswire  on February 10, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDLp4YcJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4585","BK4082","LU2065731478.USD","TMDX","BK4588"],"gpt_icon":0},{"id":"2610658248","title":"TransMedics erhält vollständige FDA-IDE-Zulassung für OCS Heart ENHANCE Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2610658248","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610658248?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:02","pubTimestamp":1770642163,"startTime":"0","endTime":"0","summary":"TransMedics Group Inc. hat die vollstndige und uneingeschrnkte Genehmigung der US-amerikanischen Food and Drug Administration  für die Investigational Device Exemption  der Next-Generation OCS Heart ENHANCE-Studie erhalten. Zuvor hatte das Unternehmen im Januar 2026 die vollstndige FDA-Genehmigung für die Next-Generation OCS DENOVO Lung IDE-Studie und im August 2025 eine bedingte IDE-Genehmigung für die ENHANCE Heart-Studie erhalten.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief on February 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL1WTS0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2324357040.USD","LU2065731478.USD","TMDX","BK4585","BK4082"],"gpt_icon":0},{"id":"2610581696","title":"Transmedics Receives Full and Unconditional FDA Ide Approval for Next-Generation Ocs Heart Enhance Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2610581696","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610581696?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:00","pubTimestamp":1770642003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUA3FCS2Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","TMDX","BK4082","BK4585","LU2065731478.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"2609804595","title":"TD Cowen Sticks to Its Buy Rating for TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609804595","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609804595?lang=en_us&edition=fundamental","pubTime":"2026-02-06 06:15","pubTimestamp":1770329759,"startTime":"0","endTime":"0","summary":"In a report released today, Josh Jennings from TD Cowen reiterated a Buy rating on TransMedics Group, with a price target of $170.00. According to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-sticks-to-its-buy-rating-for-transmedics-group-tmdx-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-sticks-to-its-buy-rating-for-transmedics-group-tmdx-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMDX","COWN","TD"],"gpt_icon":0},{"id":"2608875963","title":"Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), UnitedHealth (UNH) and Johnson & Johnson (JNJ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2608875963","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608875963?lang=en_us&edition=fundamental","pubTime":"2026-02-03 20:20","pubTimestamp":1770121228,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on TransMedics Group (TMDX – Research Report), UnitedHe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-transmedics-group-tmdx-unitedhealth-unh-and-johnson-johnson-jnj-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-transmedics-group-tmdx-unitedhealth-unh-and-johnson-johnson-jnj-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1934455863.HKD","LU2552382132.HKD","LU2552382215.SGD","LU0949170772.SGD","LU2505996681.GBP","IE0004445239.USD","LU1551013425.SGD","LU0889566641.SGD","IE00BKPKM429.USD","LU0128526141.USD","LU0820561818.USD","LU2362540622.SGD","LU1267930813.SGD","LU1221951129.SGD","IE00BWXC8680.SGD","LU0683600562.USD","IE00BZ1G4Q59.USD","BK4504","SG9999002232.USD","LU1037948541.HKD","LU1732799900.SGD","SGXZ31699556.SGD","LU0094547139.USD","IE00BFSS8Q28.SGD","LU2430703251.USD","LU1496350502.SGD","LU1244550221.USD","LU0211327993.USD","BK4585","LU0289739699.SGD","LU0965509101.SGD","LU1244550577.SGD","LU1894683348.USD","LU2491049909.HKD","LU0689472784.USD","LU0672654240.SGD","LU1267930573.SGD","IE00B19Z3581.USD","LU0882574055.USD","LU1430594728.SGD","TMDX","LU0211326839.USD","LU2089984988.USD","LU0158827781.USD","LU0149725797.USD","IE00BVYPNV92.GBP","LU2750360641.GBP","LU0052756011.USD","SG9999001440.SGD","LU2491050154.USD","LU2471134796.USD","LU0256863811.USD","BK4533","IE00BDGV0183.EUR","LU1551013342.USD","LU0353189763.USD","IE0009355771.USD","IE00B1XK9C88.USD","SG9999014898.SGD","SG9999001176.USD","IE00BN8TJ469.HKD","LU0738911758.USD","LU1291159041.SGD","LU2244417387.USD","LU1854103824.USD","LU1732800096.USD","LU1674673428.USD","LU0689626769.HKD","LU0316494557.USD","LU1670627923.USD","IE00BGHQF631.EUR","LU0320765646.SGD","IE00BN29S564.USD","IE00B1BXHZ80.USD","BK4007","IE00B3PB1722.GBP","LU0965508806.USD","LU0354030511.USD","IE00BLSP4452.SGD","LU0823416689.USD","IE0005OL40V9.USD","LU1153585028.USD","LU1854104046.USD","LU2125154935.USD","LU2430703095.HKD","LU2592432038.USD","SG9999014914.USD","LU1064131342.USD","IE00BJJMRZ35.SGD","LU0976567544.SGD","LU2468319806.SGD","LU1032466523.USD","LU0029874061.USD","LU0466842654.USD","LU0496365809.HKD","LU0098860793.USD","LU1894683264.USD","BK4137","LU0342679015.USD","IE00BJT1NW94.SGD","LU0965509283.SGD","LU1934455194.USD","LU0266013472.USD","LU0985320562.USD","LU2111349929.HKD","LU0310800965.SGD","LU1280957306.USD","LU2129689431.USD","LU1585245621.USD","LU2347655156.SGD","LU2271345857.HKD","IE0004445015.USD","LU2357305700.SGD","UNH","LU0114720955.EUR","LU1066051498.USD","BK4550","LU1084165304.USD","LU1720051108.HKD","IE00BVYPNW00.USD","LU0320765059.SGD","LU1059921491.USD","LU2360032135.SGD","LU2461242641.AUD","LU2471134879.HKD","LU2362541513.USD","LU2065731478.USD","LU1074936037.SGD","LU2361044865.SGD","SG9999014906.USD","IE00BJJMRX11.SGD","LU0345769631.USD","LU0345769128.USD","LU1037948897.HKD","LU1069347547.HKD","SG9999013999.USD","LABU","LU0109391861.USD","LU0861579265.USD","LU1988902786.USD","BK4532","LU0234570918.USD","LU2361044949.HKD","LU2491050071.SGD","IE00BZ9MQY76.HKD","LU0417517546.SGD","UNHW","SGXZ99366536.SGD","IE00B19Z8X17.USD","LU0070217475.USD","LU1003077747.HKD","LU1032955483.USD","LU1674673691.USD","LU0011850046.USD","LU0820561909.HKD","LU2362541273.HKD","LU0553294199.USD","LU1718418525.SGD","SG9999017495.SGD","IE00B19Z3B42.SGD","LU0128525929.USD","UNHG","LU1778281490.HKD","LU1323610961.USD","LU2264538146.SGD","IE00BFXG1179.USD","LU0353189680.USD","LU1267930730.SGD","LU0661504455.SGD","LU1066051811.HKD","SG9999014880.SGD","LU2471134523.USD","IE00B894F039.SGD","SGXZ81514606.USD","LU0345770308.USD","LU0545039389.USD","LU0965509010.AUD","LU2242649171.HKD","IE00B775H168.HKD","LU0211326755.USD","IE00BBT3K403.USD","IE00BKVL7J92.USD","IE00BJJMRY28.SGD","BK4581","LU1814569148.SGD","LU1935042991.SGD","IE000M9KFDE8.USD","IE00B2B36J28.USD","LU1057294990.SGD","LU1506573853.SGD","LU0310799852.SGD","IE00B4JS1V06.HKD","LU1548497426.USD","LU0029864427.USD","LU0820562030.AUD","LU1791710400.SGD","IE00BSNM7G36.USD","IE0002141913.USD","LU1023059063.AUD","LU1791710582.SGD","LU2279689827.SGD","IE00B19Z9P08.USD","LU2125154778.USD","LU2471134952.CNY","LU1221951046.USD","LU1066053197.SGD","LU0107464264.USD","LU1267930490.SGD","LU2028103732.USD","LU2361045086.USD","LU2023251221.USD","BK4592","LU0203345920.USD","LU2129689605.HKD","LU2750360997.AUD","LU2089283258.USD","BK4559","IE0002270589.USD","LU0238689110.USD","LU0158827948.USD","LU0310800379.SGD","LU0943347566.SGD","LU1119994496.HKD","BK4082","LU0053666078.USD","IE00B19Z8W00.USD","LU2211815571.USD","LU2236285917.USD","SGXZ57979304.SGD","LU0432979614.USD","LU1066051225.USD","IE00BLSP4239.USD","BK4154","LU1720051017.SGD","LU2129689514.USD","IE00B3T34201.USD","LU1670628061.USD","LU1261432733.SGD","JNJ","LU1035773651.USD","LU0640476718.USD","IE0034235303.USD","BK4534","IE00B4R5TH58.HKD","LU1162221912.USD","IE00B7SZLL34.SGD","LU1989771016.USD","LU2133065610.SGD","LU0354030438.USD","LU0097036916.USD","IE00BFSS7M15.SGD","SG9999001176.SGD","LU0795875086.SGD","BK4566","LU0708994859.HKD","LU0251132253.USD","LU2602419157.SGD","LU1934455277.USD","XBI","LU2430703178.SGD","SG9999002224.SGD","LU1061106388.HKD","IE00B19Z9505.USD","LU2552382058.USD","LU0795875169.SGD","IE00B19Z9Z06.USD","LU0203347892.USD","SGXZ51526630.SGD","LU0528227936.USD","LU1267930227.SGD","LU0557290698.USD","LU0912757837.SGD","LU2089284900.SGD","BK4568","LU0787776722.HKD","LU0124676726.USD","IE00BFTCPJ56.SGD","LU0792757196.USD","LU2087625088.SGD","IE00B7KXQ091.USD","LU0058720904.USD","LU0211328371.USD","LU0708995401.HKD","LU0079474960.USD","LU1196500208.SGD","LU0122379950.USD","LU0128525689.USD","LU1914381329.SGD","LU0456855351.SGD","LU1244550494.USD","LU2112291526.USD","LU0198837287.USD","LU1983299246.USD","SG9999018865.SGD","LU0077335932.USD","BK4588","LU2324357040.USD","LU0187121727.USD","LU2505996509.AUD","LU1929549753.HKD","LU0234572021.USD","SG9999018857.SGD","LU0048584097.USD","IE00B42XCP33.USD","LU0345770993.USD"],"gpt_icon":0},{"id":"2607650078","title":"Did Nasdaq 100 Inclusion Just Shift TransMedics Group’s (TMDX) Organ-Transplant Tech Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2607650078","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607650078?lang=en_us&edition=fundamental","pubTime":"2026-01-31 04:30","pubTimestamp":1769805056,"startTime":"0","endTime":"0","summary":"TransMedics Group’s recent inclusion in the Nasdaq 100 index recognizes the company’s role in advancing organ preservation and transplant technology through its Organ Care System platform.\nThis index addition underscores how TransMedics’ transplant-focused medical technology has moved into the mainstream of large-cap growth benchmarks, potentially broadening its investor base.\nWith this index inclusion spotlighting TransMedics’ organ transplant innovation, we’ll examine how the development...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/did-nasdaq-100-inclusion-just-shift-transmedics-groups-tmdx","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/did-nasdaq-100-inclusion-just-shift-transmedics-groups-tmdx","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065731478.USD","LU2324357040.USD","BK4585","BK4082","TMDX","BK4588"],"gpt_icon":0},{"id":"2606283211","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: TransMedics Group (TMDX) and Steris (STE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2606283211","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606283211?lang=en_us&edition=fundamental","pubTime":"2026-01-26 18:50","pubTimestamp":1769424618,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on TransMedics Group (TMDX – Research Report) and Ste...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-transmedics-group-tmdx-and-steris-ste-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-transmedics-group-tmdx-and-steris-ste-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","STE","BK4082","LU2324357040.USD","XLV","LU1892829315.USD","BK4588","BK4137","BK4585","LU2065731478.USD","LABU","TMDX","HCSG","XBI","BK4581","LU0128526141.USD"],"gpt_icon":0},{"id":"2605426564","title":"Is TransMedics’ Incentive‑Backed Somerville Campus Reshaping The Investment Case For TransMedics Group (TMDX)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2605426564","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605426564?lang=en_us&edition=fundamental","pubTime":"2026-01-23 10:30","pubTimestamp":1769135433,"startTime":"0","endTime":"0","summary":"TransMedics Group, Inc. previously signed a long-term lease for a new global headquarters at Assembly Innovation Park in Somerville and acquired an adjacent land parcel, aiming to relocate on or before January 2028 into a purpose-built campus integrating corporate, R&D, and advanced manufacturing functions.\nThe move is backed by proposed incentives from the Massachusetts Life Sciences Center and Somerville, including up to US$18,000,000 in performance-based tax incentives and up to...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/is-transmedics-incentivebacked-somerville-campus-reshaping-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/is-transmedics-incentivebacked-somerville-campus-reshaping-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TMDX","LU2065731478.USD","BK4585","BK4082","LU2324357040.USD","BK4588"],"gpt_icon":0},{"id":"2605048725","title":"TransMedics falls after FDA clears competitor liver transplant device","url":"https://stock-news.laohu8.com/highlight/detail?id=2605048725","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605048725?lang=en_us&edition=fundamental","pubTime":"2026-01-22 03:10","pubTimestamp":1769022614,"startTime":"0","endTime":"0","summary":"TransMedics (TMDX) shares are moving lower after Bridge to Life announced that the Food and Drug Administration has granted De Novo clearance for i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/transmedics-falls-after-fda-clears-competitor-liver-transplant-device-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/transmedics-falls-after-fda-clears-competitor-liver-transplant-device-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMDX","BK4082","BK4588","BK4585","LU2065731478.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"2605414044","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: TransMedics Group (TMDX), Beam Therapeutics (BEAM) and Boston Scientific (BSX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605414044","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605414044?lang=en_us&edition=fundamental","pubTime":"2026-01-21 07:50","pubTimestamp":1768953032,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on TransMedics Group (TMDX – Research Report), Beam T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-transmedics-group-tmdx-beam-therapeutics-beam-and-boston-scientific-bsx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-transmedics-group-tmdx-beam-therapeutics-beam-and-boston-scientific-bsx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","LU1023059063.AUD","LU1989764664.SGD","LU0029874061.USD","LU1989772923.USD","LU1057294990.SGD","LU2362541513.USD","HCSG","LU0345769631.USD","LU0528227936.USD","LU1720051108.HKD","LU2362540622.SGD","BK4585","LU2087625088.SGD","BK4588","TMDX","LU0345769128.USD","IE00BFTCPJ56.SGD","LU2506952097.USD","BEAM","LU2506951875.HKD","BK4611","LU2362541273.HKD","IE00B2B36J28.USD","LU2112291526.USD","BK4556","LU1720051017.SGD","LU1989772840.SGD","LU1804176565.USD","LU2506951958.HKD","LU2244417387.USD","SGXZ57979304.SGD","LABU","SG9999001176.USD","XLV","LU1989771016.USD","LU0432979614.USD","LU2242649171.HKD","LU0353189680.USD","BSX","XBI","LU0353189763.USD","BK4082","LU2491049909.HKD","LU1718418525.SGD","LU0187121727.USD","LU1989764748.USD","LU0114720955.EUR","IE00BJT1NW94.SGD","LU0882574055.USD"],"gpt_icon":0},{"id":"2603674550","title":"How TransMedics’ Somerville Campus Bet At TransMedics Group (TMDX) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2603674550","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603674550?lang=en_us&edition=fundamental","pubTime":"2026-01-15 11:29","pubTimestamp":1768447742,"startTime":"0","endTime":"0","summary":"TransMedics Group, Inc. has recently signed a long-term lease for a 498,000-square-foot global headquarters at Assembly Innovation Park in Somerville, Massachusetts, and acquired adjacent land to build an integrated campus consolidating corporate, R&D, and advanced manufacturing operations, with relocation planned by January 2028.\nA key aspect of this expansion is the extensive public support, including up to US$18,000,000 in state job-linked tax incentives and up to US$18,000,000 in local...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/how-transmedics-somerville-campus-bet-at-transmedics-group-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/how-transmedics-somerville-campus-bet-at-transmedics-group-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2324357040.USD","LU2065731478.USD","BK4585","BK4588","BK4082","TMDX"],"gpt_icon":0},{"id":"2603487066","title":"TransMedics’ DENOVO Trial: New Lung Preservation Study Could Shape Future Growth for TMDX","url":"https://stock-news.laohu8.com/highlight/detail?id=2603487066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603487066?lang=en_us&edition=fundamental","pubTime":"2026-01-15 00:32","pubTimestamp":1768408345,"startTime":"0","endTime":"0","summary":"Transmedics Group ($TMDX) announced an update on their ongoing clinical study. Study Overview: The “Decreasing Edema With a Novel OCS Solution (DEN...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transmedics-denovo-trial-new-lung-preservation-study-could-shape-future-growth-for-tmdx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transmedics-denovo-trial-new-lung-preservation-study-could-shape-future-growth-for-tmdx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","LU2065731478.USD","BK4588","BK4585","LU2324357040.USD","TMDX"],"gpt_icon":0},{"id":"2603226635","title":"TransMedics Group Inc. Unveils Presentation on Revolutionizing Organ Transplantation with OCS Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2603226635","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603226635?lang=en_us&edition=fundamental","pubTime":"2026-01-13 07:49","pubTimestamp":1768261795,"startTime":"0","endTime":"0","summary":"TransMedics Group Inc. has released a presentation highlighting its advancements in organ transplantation technology. The company detailed the limitations of traditional cold storage for donor organs, noting issues such as severe time-dependent injury and lack of assessment capabilities, which contribute to significant underutilization of donor organs in the United States. The presentation introduced the Organ Care System  platform, described as the only multiorgan, portable warm perfusion platform, which aims to minimize ischemic damage, enable ex-vivo organ optimization, and allow continuous clinical assessment. The latest generation OCS Kidney technology features integrated biosensors, continuous data capture, and near-physiologic preservation for extended organ viability and functional assessment. The company also referenced a substantial body of prospective clinical evidence supporting the platform's effectiveness with both DBD and DCD organs. You can access the full presentation ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL7gPh53:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","TMDX","BK4588","BK4585","LU2324357040.USD","BK4082"],"gpt_icon":0},{"id":"2602548863","title":"TransMedics signs long-term lease for new global headquarters in MA","url":"https://stock-news.laohu8.com/highlight/detail?id=2602548863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602548863?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:15","pubTimestamp":1768223728,"startTime":"0","endTime":"0","summary":"TransMedics (TMDX) Group announced the signing of a long-term lease for its new global headquarters at Assembly Innovation Park in Somerville, as w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/transmedics-signs-long-term-lease-for-new-global-headquarters-in-ma-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/transmedics-signs-long-term-lease-for-new-global-headquarters-in-ma-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKDWB100.SGD","BK4566","MA","IE00BFSS7M15.SGD","LU0345769128.USD","LU2236285917.USD","LU2456880835.USD","LU0061475181.USD","LU0210533765.USD","LU0786609619.USD","LU0823421416.USD","LU0823434583.USD","LU0820561818.USD","LU0094547139.USD","LU2720916845.USD","BK4227","LU2543165471.USD","LU0942090050.USD","LU0943347566.SGD","IE0005OL40V9.USD","LU0096362180.USD","LU2250418816.HKD","LU0353189763.USD","LU2552382215.SGD","IE00BJJMRY28.SGD","TMDX","LU1718418525.SGD","IE00B7KXQ091.USD","LU2077746001.SGD","SGXZ81514606.USD","LU0316494557.USD","IE00BYQQ9H92.USD","LU1145028129.USD","LU0320765059.SGD","LU0823421333.USD","LU1153585028.USD","LU1551013342.USD","LU2092937148.SGD","LU2552382132.HKD","LU0345769631.USD","LU2324357040.USD","LU2420271590.USD","LU0210536198.USD","LU0234572021.USD","LU0708995401.HKD","LU2552382058.USD","LU0109392836.USD","LU0096364046.USD","LU2092627202.USD","LU0820562030.AUD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transmedics.com","stockEarnings":[{"period":"1week","weight":0.037},{"period":"1month","weight":-0.0048},{"period":"3month","weight":-0.0777},{"period":"6month","weight":0.1471},{"period":"1year","weight":0.8714},{"period":"ytd","weight":0.1069}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.026649},{"month":2,"riseRate":0.714286,"avgChangeRate":0.142274},{"month":3,"riseRate":0.333333,"avgChangeRate":0.01893},{"month":4,"riseRate":0.666667,"avgChangeRate":0.108774},{"month":5,"riseRate":0.5,"avgChangeRate":0.127373},{"month":6,"riseRate":1,"avgChangeRate":0.158462},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.012617},{"month":8,"riseRate":0.571429,"avgChangeRate":0.040414},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.096617},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.144574},{"month":11,"riseRate":0.857143,"avgChangeRate":0.223183},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.026786}],"exchange":"NASDAQ","name":"TransMedics Group, Inc.","nameEN":"TransMedics Group, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TransMedics Group, Inc.(TMDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TransMedics Group, Inc.,TMDX,TransMedics Group, Inc.股票,TransMedics Group, Inc.股票老虎,TransMedics Group, Inc.股票老虎国际,TransMedics Group, Inc.行情,TransMedics Group, Inc.股票行情,TransMedics Group, Inc.股价,TransMedics Group, Inc.股市,TransMedics Group, Inc.股票价格,TransMedics Group, Inc.股票交易,TransMedics Group, Inc.股票购买,TransMedics Group, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TransMedics Group, Inc.(TMDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}